ArticleBMJ neurology open2024

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial.

Michael Benatar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.